Evidence map›Paper›PMID 41764402›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Molecularly Engineered Phenoxazinone-Skeleton Cascade-Activated NIR Probes for Monitoring Fe

Lixia Guo, Tao Liu, Hongfei Wang, Qi Gao, Zhaobo Yang, Zumeng Wang, Chenlong Li, Yubing Kang, Kahleong Lim, Wen Liu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lixia GuoThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Taiyuan, P. R. China.
Tao LiuDepartment of Chemical and Materials Engineering, Lyuliang University, Lvliang, P. R. China.
Hongfei WangSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Qi GaoSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Zhaobo YangSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Zumeng WangSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Chenlong LiSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Yubing KangSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Kahleong LimLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Wen LiuSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Li LuSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.
Chengwu ZhangSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, P. R. China.ORCID https://orcid.org/0000-0003-4681-6534

Funding

National Natural Science Foundation of China 82472030Shanxi Scholarship Council of China 2024-079The China Postdoctoral Science Foundation 2023M732141
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, in which ferroptosis may be the crucial event leading to dopaminergic neuron death. Accumulated ferrous ions (Fe

Indexed as

FerroptosisFluorescent DyesIronParkinson DiseaseAnimalsDopaminergic NeuronsFluorescent Chemosensor CompoundsHumansMiceOxidative StressViscosityFluorescent Chemosensor CompoundsFluorescent DyesIroncascade‐activated probesferroptosisferrous ionParkinson's diseasequercetinviscosity

Identifiers

PMID41764402
PMCPMC13159097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.